We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4523 total record number 214 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 1 out of 453
4523 citations found

Methylglyoxal suppresses microglia inflammatory response through NRF2-IκBζ pathway

Wei, SL;Yang, Y;Si, WY;Zhou, Y;Li, T;Du, T;Zhang, P;Li, XL;Duan, RN;Duan, RS;Yang, CL;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Electroacupuncture at ST36 acupoint regulates stem cells during experimental autoimmune encephalomyelitis

Chen, X;Wang, Y;Ji, J;Li, C;Zhuang, W;Luo, J;Shi, Y;Lin, Q;Wu, J;Li, A;Wang, J;Meng, Y;Zhang, S;Lang, X;Liu, X;Sun, B;Li, H;Liu, Y;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

New characterization and safety evaluation of human limbal stem cells used in clinical application: fidelity of mitotic process and mitotic spindle morphologies

Marija Zekušić1 Marina Bujić Mihica1 Marija Skoko1 Kruno Vukušić2 Patrik Risteski2 Jelena Martinčić2 Iva M. Tolić2 Krešo Bendelja3 Snježana Ramić1 Tamara Dolenec1 Ivana Vrgoč Zimić1 Dominik Puljić1 Ivanka Petric Vicković1 Renata Iveković1 Ivanka Batarilo4 Uršula Prosenc Zmrzljak5 Alan Hoffmeister6 Tiha Vučemilo1

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Analysis of Differential TLR Activation in a Mouse Model of Multiple Sclerosis

Suvieri, C;Volpi, C;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Multi-Compartmental Analysis of the Murine Pulmonary Immune Response by Spectral Flow Cytometry

Chang, MY;Brune, JE;Black, M;Altemeier, WA;Frevert, CW;

Product: LPS from Escherichia coli O111:B4

  • Lipopolysaccharide, Bleomycin, House Dust Mite Administration

    Lipopolysaccharide (LPS, Escherichia coli O111: B4, List Biological Laboratories, Campbell, CA, USA) was administered by oropharyngeal aspiration under isoflurane anesthesia at a dose of 2.0 mg/kg of mouse body weight in 50μL of PBS. …

    Product #201 – LPS from Escherichia coli O111:B4

A regulatory circuit controlled by extranuclear and nuclear retinoic acid receptor α determines T cell activation and function

Larange, A;Takazawa, I;Kakugawa, K;Thiault, N;Ngoi, S;Olive, ME;Iwaya, H;Seguin, L;Vicente-Suarez, I;Becart, S;Verstichel, G;Balancio, A;Altman, A;Chang, JT;Taniuchi, I;Lillemeier, B;Kronenberg, M;Myers, SA;Cheroutre, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

“Repeated B. pertussis Infections are Required to Reprogram Acellular Pertussis Vaccine-primed Host Responses in the Baboon Model”

Kapil, P;Wang, Y;Zimmerman, L;Gaykema, M;Merkel, TJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease

Garretti, F;Monahan, C;Sloan, N;Bergen, J;Shahriar, S;Kim, SW;Sette, A;Cutforth, T;Kanter, E;Agalliu, D;Sulzer, D;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Immunizations

    8- to 12-week-old male and female mice were immunized subcutaneously with a 100 μl emulsion of 100 μg α-syn32-46 peptide (A&A peptides; San Diego, CA) dissolved in PBS with Complete Freund Adjuvant (CFA) containing 200 μg M. tuberculosis H37Ra (BD Difco Adjuvant, Fisher Scientific, Cat #DF0638-60-7; Waltham, MA). The day of immunization was designated as day 0. Mice received a boost with the same immunization dose two weeks later. Mice received intravenous injections of 400 ng of B. pertussis toxin (List Biological Laboratories, Cat #181; Campbell, CA) 14- and 16-days post-initial immunization (day 0 and 2 post boost). …

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers

Gress, C;Vogel-Claussen, J;Badorrek, P;Müller, M;Hohl, K;Konietzke, M;Litzenburger, T;Seibold, W;Gupta, A;Hohlfeld, JM;

Product: LIST™ HPT™ from Escherichia coli O113

  • Methods
    In a monocentric, randomized, double-blind, placebo-controlled, parallel-group, phase I trial, 57 healthy, smoking subjects were treated for 28 days with either oral BI 1026706 100 mg bid or placebo. At day 21, turbo-inversion recovery magnitude magnetic resonance imaging (TIRM MRI) was performed. On the last day of treatment, pre-challenge bronchoalveolar lavage fluid (BAL) and biopsies were sampled, followed by segmental LPS challenge (40 endotoxin units/kg body weight) and saline control instillation in different lung lobes. Twenty-four hours later, TIRM MRI was performed, then BAL and biopsies were collected from the challenged segments. In BAL samples, cells were differentiated for neutrophil numbers as the primary endpoint. Other endpoints included assessment of safety, biomarkers in BAL (e.g. interleukin-8 [IL-8], albumin and total protein), B1R expression in lung biopsies and TIRM score by MRI as a measure for the extent of pulmonary oedema.

    … Next, Lipopolysaccharide (Endotoxin from E. coli Type O113 provided by National Institutes of Health Clinical Center, Bethesda, Maryland, USA and produced by List Biological Laboratories Inc., Campbell, California, USA) at a dose of 40 endotoxin units (E.U.)/kg …

    Product #9433 – GMP LPS Lipopolysaccharide List™ Hpt™ From Escherichia Coli Type O113